DadFinStart your free week
DadFin › Stocks › Consumer Defensive › CL

Colgate-Palmolive Company (CL) stock score

Consumer Defensive · Household & Personal Products · United States

$88.27 ▲ +0.19% today

26.7
Dad Score, out of 100
weak

Colgate-Palmolive Company (CL) is a Household & Personal Products company in the Consumer Defensive sector, listed in the United States. On DadFin's weekly run it scores 26.7 out of 100 on the Dad Score, a weak reading that places the business ahead of 27% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Consumer Defensive it ranks #159 of 232. Its strongest axes are quality, liquidity and macro; its weakest are valuation and price action.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Below average
Quality
Strong
Growth
Average
Price action
Weak
Risk
Below average
Conviction
Below average
Liquidity
Strong
Macro
Above average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)33.2×
P/E (forward)20.5×
Dividend yield2.47%
Return on capital33.7%
Operating margin21.0%
Revenue growth (YoY)+1.4%
FCF yield4.9%
Net debt / EBITDA1.29×
Piotroski F-Score5 / 9
52-week change+11.5%
Market cap$67.2B
Next earningsOct 30, 2026

What subscribers see on CL

Start your free weekSubscriber? Open the full research →

Household & Personal Products peers

StockCompanyDad ScoreBandMarket cap
PGThe Procter & Gamble Company46.1middling$336.8B
ULUnilever PLC34.5weak$128.6B
ELThe Estée Lauder Companies Inc.53.8middling$33.3B
KVUEKenvue Inc.53.1middling$33.0B
KMBKimberly-Clark Corporation21.9weak$31.3B
CHDChurch & Dwight Co., Inc.59.6middling$22.4B
CLXThe Clorox Company8.9poor$9.7B
ELFe.l.f. Beauty, Inc.58.6middling$6.2B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.